Tag: Pharmaceutical Plant Construction

Catalent in Shanghai has reached the commissioning Stage

Catalent Pharma Solutions has announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China, has reached the commissioning stage and is scheduled to be c...

Orchard Therapeutics is about to build New Gene Therapy Site

Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene thera...

Lonza to set up a new biologics facility using GE Healthcare’s platform

test tube
Lonza (Switzerland) announced an agreement with GE Healthcare (USA) under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (China).

Novo Nordisk to invest $22 million in its US facility

Novo Nordisk
Novo Nordisk(Denmark), the world’s leading diabetes care company, will invest $22 million at its Clayton facility in Johnston County (North Carolina, USA). The move comes just ten months after Novo...

GE Healthcare to launch a new biotech manufacturing facility in UK

ge-healthcare
GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage (UK).

CASI Pharmaceuticals to build new manufacturing site in China

drugs
CASI Pharmaceuticals nnounced that it has entered into framework agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone.

WuXi Biologics to construct a new biologics manufacturing facility

wuxi-biologics
WuXi Biologics (China) announced that it has commenced the construction of a Biologics Manufacturing Center of excellence, in the city of Shijiazhuang, one hour train from Beijing.

Aspen to invest in sterile anaesthetics manufacturing

aspen
Pharmaceutical group Aspen Pharmacare (the Republic of South Africa) will make an additional investment into the manufacturing of sterile anaesthetics at its Port Elizabeth manufacturing site.

Russian-Azerbaijani pharma company to be launched at the end of 2018

hayat
The Azerbaijani-Russian joint venture will be commissioned in December 2018. In December, the drug packaging line will be put into operation, which is the first stage of the project.

PSK Pharma is preparing to launch a new plant in the SEZ Dubna

psk-pharma
Construction of the PSK Pharma plant began in April 2017. Asthma medications and drugs for treatment of chronic lung diseases will be the main products of the new facility.

AGC Biologics will set up a new facility in Japan

test tube
AGC Biologics announced that it will establish a new state of the art process development and manufacturing facility at its CDMO facility in Chiba (Japan).

Vertex constructs the third stage of the pharma complex for 2.3 billion rubles

vertex
Pharmaceutical company VERTEX is now constructing the third stage of the Innovation and Production Complex in the Novoorlovskaya site, Special Economic Zone Saint-Petersburg.

BIOCAD and SPH agreed to start pharmaceutical production in China

biocad_china
BIOCAD and Shanghai Pharmaceuticals Holding used Eastern Economic Forum 2018 to sign a memorandum of understanding regarding the establishment of two joint ventures.

BIOCAD and Gem-Standard increase financing for projects at St Petersburg SEZ

biocad
On August 30, the Expert Council of Special Economic Zone (SEZ) 'St. Petersburg' approved the amendments for two ongoing projects of the existing SEZ residents - CJSC Biocad and Gem-Standard LLC.

Pskov Pharma intends to start production by September 2020

moglino sez
The transfer of stones extracted from the subsoil in the Special Economic Zone Moglino is a good tradition, symbolizing the beginning of the construction of new production facilities.

Uzbekistan has agreed to build a pharma plant with Ukrainian manufacturer

farmak
Filya Zhebrovskaya, Chairman of the Board of Directors of the Ukrainian enterprise Farmak, and Alisher Abdualiyev, Uzbek Ambassador to Ukraine, agreed on the construction of a new pharma plant.